Anzeige
❌
Mehr »
Dienstag, 17.11.2026 - Börsentäglich über 12.000 News
Die nächste Sicherheitsgeneration: Quantenresistente Technologie
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JCLB | ISIN: FR0011049824 | Ticker: 4ZG
Stuttgart
16.11.26 | 17:32
4,220 Euro
0,00 % 0,000
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
MEDIAN TECHNOLOGIES Chart 1 Jahr
5-Tage-Chart
MEDIAN TECHNOLOGIES 5-Tage-Chart
RealtimeGeldBriefZeit
4,4004,41009:32
4,2504,31016.11.

Aktuelle News zur MEDIAN TECHNOLOGIES Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
08:42Eyonis Inc, a Median Technologies Company, Wins "Rising Star" Digital Health & AI Award for eyonis LCS Lung Cancer Screening200Award recognizes eyonis LCS for its transformative ability to save lives through earlier and more accurate lung cancer detection and diagnosis eyonis LCS is the first and only FDA-cleared...
► Artikel lesen
09.11.Median Technologies to Participate in the Stifel 2026 Healthcare Conference273Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
05.11.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of October 31, 2026318Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
MEDIAN TECHNOLOGIES Aktie jetzt für 0€ handeln
29.10.Median Technologies Reports H1 2026 Financial Results and Q3 Business Highlights544eyonis LCS Advances U.S. Commercial Rollout as iCRO Achieves Double-Digit Revenue Growth and Record €90.9 Million Order Backlog in Q3 Record quarterly revenue of €6.7 million in Q3 2026,...
► Artikel lesen
21.10.Median Technologies to Showcase iCRO's Central and AI-Powered Imaging Services for Oncology Clinical Trials at ESMO 2026351Median Technologies is a leading provider of central imaging services and AI-powered image analysis for oncology clinical trials The Company will host an interactive session on the implementation...
► Artikel lesen
20.10.Median Technologies Strengthens Its Engagement with the International Lung Cancer Screening Community at the 50th I-ELCAP Conference in New York543Median Technologies and its U.S. subsidiary eyonis Inc. will present eyonis LCS at this landmark meeting of the international lung cancer screening community I-ELCAP has played a pioneering...
► Artikel lesen
14.10.eyonis Inc., a Median Technologies Company, to Present Study Results Supporting eyonis LCS Performance Claims at CHEST 2026639Study demonstrated 93.3% sensitivity, 92.4% specificity and 99.9% negative predictive value for eyonis LCS eyonis LCS is the first and only FDA-cleared AI/ML-based Software as a Medical...
► Artikel lesen
12.10.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of September 30, 2026409Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
15.09.Median Technologies Secures One of the Largest iCRO Projects in Its History 513€8.4 Million global phase III oncology imaging project expands Median's iCRO order backlog and provides additional revenue visibility Regulatory News: Median Technologies (FR0011049824, ALMDT...
► Artikel lesen
10.09.Median Technologies: H2 2026 Financial Communication Calendar416Regulatory News: Median Technologies (FR0011049824, ALMDT, PEA-PME scheme eligible, "Median" or the "Company"), developer of eyonis, a suite of artificial intelligence (AI) powered Software as...
► Artikel lesen
08.09.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of August 31, 2026538Pursuant to article L-223-8 II of the French "Code de commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
02.09.Median Technologies Announces Formation of Strategic Review Committee and R&D Committee to Unlock Intrinsic Value and Accelerate Its eyonis Pan-Cancer Strategy622Strategic Review to Include Potential Separation of iCRO, Potential U.S. Listing and Other Strategic Alternatives The Strategic Review Committee has been tasked with evaluating a broad range...
► Artikel lesen
10.08.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of July 31, 2026531Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
30.07.Median Technologies and Olea Medical, a Canon Medical Systems Company, Partner to Advance Commercial Deployment of AI-Powered eyonis LCS for Lung Cancer Screening1.142Both entities have signed a global strategic commercial agreement. The agreement marks an important new step in the execution of Median's partnership-driven commercialization strategy for...
► Artikel lesen
22.07.Median Technologies Reports Record iCRO Backlog, Accelerates Commercial Rollout of eyonis LCS and Development of New Indications Across the eyonis Portfolio681Strengthened cash position at €60.8 million as of June 30, 2026, reflecting the successful €50 million capital increase completed in June 2026. Cash runway through the first half of 2028...
► Artikel lesen
15.07.Half Year Median Technologies Liquidity Contract Statement475First half of 2026 Regulatory News: Under the liquidity contract entrusted by Median Technologies (FR0011049824, ALMDT, "Median" or "the Company") to TP ICAP (Europe), the following resources...
► Artikel lesen
06.07.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of June 30, 2026464Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.07.Median Technologies' eyonis LCS Obtains CE Marking1.039European marketing authorization follows U.S. FDA clearance of eyonis LCS, Median's AI-based Software as a Medical Device designed to aid in the detection and diagnosis of lung cancer in screening...
► Artikel lesen
08.06.Median Technologies: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of May 31, 2026435Pursuant to article L-223-8 II of the French "code de Commerce" and 223-16 of the AMF's General Regulations. Regulatory News: Median Technologies (Paris:ALMDT): Total number of shares...
► Artikel lesen
03.06.Median Technologies Announces Successful Upsized Capital Increase of € 50 Million1.275Not to be published, distributed or disseminated, directly or indirectly, in the United States of America, Australia, Canada, South Africa and Japan Great Success of the capital increase with...
► Artikel lesen
1 2 3 Weiter >>
45 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1